News
The most comprehensive analysis of rheumatoid arthritis data to date reveals that demographic changes and uneven health ...
5h
HealthDay on MSNRheumatoid Arthritis On The Rise WorldwideA new AI-powered study reveals that cases of rheumatoid arthritis (RA) are on the rise worldwide. The autoimmune disease ...
A global surge in rheumatoid arthritis with local hotspots highlights the need for targeted public health interventions.
Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from ...
12h
HealthDay on MSNRheumatoid Arthritis On The Rise Worldwide, AI-Powered Study EstimatesKey TakeawaysRheumatoid arthritis is on the rise around the worldCases are up 13% since 1990Fewer people are dying from RA, ...
Lots of people are doing great research all across the whole spectrum of rheumatoid arthritis, from hard-to-treat disease, to early disease, to severe disease, various forms of rheumatoid arthritis ...
There's a number of risk factors for rheumatoid arthritis that we know about. There's genetic factors, there's certain genes, including something we call the “shared epitope” that put people at risk ...
Objective The objectives of this study were: (1) to describe burden of rheumatoid arthritis (RA) and trends from 1990 to 2019 using the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) ...
Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...
Data from the Phase IIIb APEX study, presented at EULAR 2025, show that guselkumab (Tremfya) improved joint and skin symptoms and inhibited structural joint damage in patients with active psoriatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results